Our Blog - Tag: Medtronic

Medtronic recently issued a recall of various insulin pump models due to a faulty design that allows users to accidentally deliver the maximum amount of insulin by inadvertently pressing a button. This recall concerns an enormous amount of devices: nearly 560,000 insulin pumps have been recalled. A total of 444,374 of these devices are in…

Delivery of the proper amount of insulin at the right time is critical for anyone suffering from diabetes. Individuals living with diabetes must depend on medical supply companies to provide the products they need to maintain a healthy blood sugar level. But what happens when something goes wrong? In March of this year, the Medtronic…

Medtronic recently sent an urgent letter to physicians warning that two of its SynchroMed drug infusion pumps have product defects that may cause the pumps to stop working. As of last summer, the U.S. Food and Drug Administration (FDA) had received more than 550 complaints regarding SynchroMed pump failures. The FDA has decided to classify…

In our last post we discussed the pending litigation against one of the nation’s largest medical device manufacturers arising out of the off-label use of its bone grafts. Medtronic’s INFUSE Bone Grafts were used in several types of spinal surgeries without approval by the Food and Drug Administration. As a result, many patients now suffer…

When the makers of a drug or medical device pay doctors to provide research on the safety and efficacy of the treatment, can the results be trusted? In the case of Medtronic’s bone growth product, INFUSE, there is major controversy over the fact the drug and device maker paid researchers a substantial amount to identify…